The Therapeutic Effect of Zinc Sulfate on Neonatal Hyperbilirubinemia

Document Type: Original Article

Authors

1 Department of Pediatric Endocrinology and Metabolism .Imam Reza Hospital , Faculty of Medicine, Mashhad University of Medical Sciences , Mashhad, Iran

2 Neonatal Research Center, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3 Pharmaceutical and Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Background: Approximately 60% of term neonates and 80% of preterm ones suffer from hyperbilirubinemia in their
first week of life. This study sought to characterize the therapeutic effect of oral zinc sulfate on neonatal
hyperbilirubinemia.
Methods: In this randomized, double-blind, placebo-controlled clinical trial, 70 term neonates with total serum
bilirubin (TSB) level ≥ 20 mg/dl were enrolled. Thirty-four cases were treated with phototherapy and zinc (10 mg/day,
single dose) as case, while the remainder received phototherapy plus placebo. TSB level was measured at the onset of
the intervention, as well as 12, 24 and 48 h after the intervention and compared with each other.
Results: The mean TSB levels were significantly lower in the zinc group after 12, 24 and 48 h (P=0.038, 0.005, 0.001,
respectively). The mean durations of phototherapy in the case and control groups were 2.03±0.174 and 2.33±0.478
days, respectively, being significantly less in the case group (P=0.002).
Conclusion: This study revealed that oral zinc sulfate at a single dose of 10 mg/day diminished TSB level and duration
of phototherapy.

Keywords


1. Rana N, Mishra S, Bhatnagar S, Paul V, Deorari AK, Agarwal R. Efficacy of zinc in reducing hyperbilirubinemia among at-risk neonates: a randomized, double-blind, placebo-controlled trial. Indian J Pediatr. 2011; 78(9):1073-8.

 2. Stoll BJ, Kliegman RM. Jaundice and hyperbilirubinemia. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BM, editors. Nelson textbook of pediatric. 17th ed. Philadelphia: WB Saunders; 2011. P. 592-8.

 3. Mohammadzadeh A, Farhat AS, Iranpour R. Effect of clofibrate in jaundiced term newborns. Indian J Pediatr. 2005; 72(2):123-6.

 4. Kaplan M, Wong RJ, Sibley E, Stevenson DK. Neonatal jaundice and liver disease. In: Martin RJ, Fanaroff A, Walsh MC, editors. Fanaroff and Martin's Neonatal-Perinatal Medicine: diseases of the fetus and infant. 9th ed. New York: Elsevier Health Sciences; 2011. P. 1443-96.

5. Shapiro SM. Bilirubin toxicity in the developing nervous system. Ped Neurol. 2003; 29(5):410–21. 6. Odell GB, Gutchetr GR, Whitington PF, Yang G. Enteral administration of agar as an effective adjunct to phototherapy of neonatal hyperbilirubinemia. Pediatr Res. 1983; 17(10):810–4.

7. Mendez-Sanchez N, Roldan-Valadez E, Flores MA, Cardenas-Vazquez R, Uribe M. Zinc salts precipitate unconjugated bilirubin in vitro and inhibit enterohepatic cycling of bilirubin in hamsters. Eur J Clin Invest. 2001; 31(9):773–80.

 8. Vitek L, Munchova L, Zelenka J, Zadinova M, Malina J. The effect of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. J Pediatr Gastroenterol Nutr. 2005; 40(2):135–40.

 9. Mendez-Sanchez N, Martinez M, Gonzalez V, RoldanValadez E, Flores MA, Uriebe MA. Zinc Sulfate inhibits the enterohepatic circulation of unconjugated bilirubin in subjects with Gilbert syndrome. Ann Hepatol. 2002; 1(1):40–3.

 10. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn Infant 35 or more weeks of gestation. Pediatrics. 2004; 114(1):297–316.

11. Maamouri G, Boskabadi H, Mafinejad S, Bozorgnia Y, Khakshur A. Efficacy of oral zinc sulfate intake in prevention of neonatal jaundice. Iran J Neonatol. 2014; 4(4):11–6.

12. Babaei H, Hemmati M, Fallahi V, Rezaei M. Effect of oral zinc sulfate in prevention of jaundice in healthy term newborns. J Kermanshah Univ Med Sci. 2014; 17(11):680–6.

13. Ebrahimimd S, Ashkani-Esfahani S, Poormahmudibs A. Investigating the efficacy of zizyphus jujuba on neonatal jaundice. Iran J Pediatr. 2011; 21(3):320-4.

14. Mohammadzade A, Farhat AS, Amiri R, Esmaely H, Bagheri S. Treatment effect of clofibrate in jaundiced low birth weight neonates. J Hematol Oncol. 2009; 26(4):100-5.

15. Mohammadzadeh A, Farhat AS, Jafarzadeh M, Mirzarahimi M, Esmaeli H, Amiri R. Prophylactic effect of clofibrate in low birth weight neonate's hyperbilirobinemia. J Chinese Clin Med. 2008, 3(3):140-4.

16. Ashraf M, Ahmadshah F, Habibullah E, Niloofar J. Prophylactic effect of clofibrate on hyperbilirubinemia in verylow birth weight twins. Br J Pharmac Res. 2014; 4(7):818-25.

 17. Mosayebi Z, Rahmani M, Behjati Ardakani S, Sheikh M, Shariat M, Rezaeizadeh G. Evaluation of serum zinc levels in hyperbilirubinemic neonates before and after phototherapy. Iran J Pediatr. 2016; 26(3):e4146.

18. Patton P, Rachmadi D, Sukadi A. Effect of oral zinc on hyperbilirubinemia in full term neonates. Paediatr Indonesian. 2011; 51(2):107-10.

 19. Lamberti LM, Walker CL, Chan KY, Jian WY, Black RE. Oral zinc supplementation for the treatment of acute diarrhea in children: a systematic review and meta-analysis. Nutrients. 2013; 5(11):4715-40.

20. Bahl R, Bhandari N, Saksena M, Strand T, Kumar GT, Bhan MK, et al. Efficacy of zinc fortified oral rehydration solution in 6- to 35-month-old children with acute diarrhea. J Pediatr. 2002; 141(5):677–82.

 21. Fischer C, Harvey P. Low risk of adverse effects from zinc supplementation. New York: The USAID Micronutrient Program; 2006.